MAM
INDV icon

Melqart Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Melqart Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.9M Buy
+684,320
New +$22.6M 2.06% 21
2025
Q4 		– Sell
-616,863
Closed -$14.9M – 56
2025
Q3 		$14.9M Buy
616,863
+449,324
+268% +$9.4M 1.98% 20
2025
Q2 		$2.47M Buy
+167,539
New +$1.95M 0.35% 29
2025
Q1 		– Sell
-104,790
Closed -$1.3M – 59
2024
Q4 		$1.3M Buy
104,790
+91,280
+676% +$939K 0.16% 46
2024
Q3 		$132K Buy
+13,510
New +$158K 0.01% 51

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Melqart Asset Management's INDV Position: Q1 2026 in Review

Melqart Asset Management opened a new position in Indivior Pharmaceuticals (INDV) in Q1 2026: 684,320 shares worth $20.9M. The stake represents 2.06% of the portfolio and ranks #21 among its holdings. This is a return to the name: Melqart Asset Management previously reported a position in INDV as recently as Q3 2025.

Melqart Asset Management first reported a position in INDV in Q3 2024 and has held it in 5 quarters since. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Melqart Asset Management held 684,320 shares of Indivior Pharmaceuticals worth $20.9M as of Q1 2026.
  • Indivior Pharmaceuticals was a new Melqart Asset Management position in Q1 2026.
  • Indivior Pharmaceuticals made up 2.06% of Melqart Asset Management's portfolio in Q1 2026, its #21 holding.
  • Melqart Asset Management first reported a position in Indivior Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Melqart Asset Management's 13F filing for Q1 2026, filed 12 May 2026.